StonvexLoading…
StonvexStonvexStonvexCore line items from AMN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.73B | $2.98B | $3.79B | $5.24B |
Operating Income | $-55.47M | $-102.67M | $338.43M | $647.10M |
Net Income | $-95.70M | $-146.98M | $210.68M | $444.05M |
EPS (Diluted) | $-2.48 | $-3.85 | $5.36 | $9.90 |
Total Assets | $2.09B | $2.42B | $2.92B | $2.89B |
Total Liabilities | $1.45B | $1.71B | $2.09B | $1.84B |
Cash & Equivalents | $33.97M | $10.65M | $32.94M | $64.52M |
Free Cash Flow OCF − CapEx | $233.83M | $239.53M | $268.48M | $577.90M |
Shares Outstanding | 38.44M | 38.08M | 37.81M | 41.88M |